BMC Gastroenterology

official impact factor 2.47

Section Editors

  • Inge Depoortere, Catholic University Leuven
  • Arthur Kaser, University of Cambridge
  • Rakesh Tandon, Pushpawati Singhania Research Institute
  • Christian Trautwein, Universitätsklinikum Aachen
  • David Watson, Flinders University
  • Joanne Young, Queensland Institute of Medical Research

Executive Editor

  • Timothy Shipley, BioMed Central

Articles

There has been an error retrieving the data. Please try again.
  • Image attributed to: Figure 1, BMC Gastroenterology 2012, 12:41

    Oral arginine reduces intestinal injury

    In a rat model, dietary L-Arginine supplementation prevents mucosal injury, decreases cell death via apoptosis and improves intestinal recovery following methotrexate (MTX)-induced intestinal injury, suggesting that oral arginine may have clinical value for the treatment of chemotherapy-induced mucositis.

    BMC Gastroenterology 2012, 12:41
  • Image attributed to: colon attribution istock

    Luteolin reduces IGF-IR signalling

    Luteolin, a flavonoid found in fruits and vegetables, reduces insulin-like growth factor-I receptor (IGF-IR) signaling in colon cancer cells, suggesting that this mechanism may contribute to luteolin-induced apoptosis and cell cycle arrest.

    BMC Gastroenterology 2012, 12:9
  • View more articles  

Scope

BMC Gastroenterology is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of gastrointestinal and hepatobiliary disorders, as well as related molecular genetics, pathophysiology, and epidemiology.

It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.

Quote

Sally Blower

"I strongly believe in the internet and open-access publishing in order to achieve scientific outreach both within academia and outside academia. Open-access allows anyone in the world with access to a computer to access scientific research. These innovative journals are becoming extremely successful and will change the nature of scientific publishing and increase the accessibility of science."

Professor Sally Blower
Semel Institute for Neuroscience & Human Behavior,
UCLA David Geffen School of Medicine, USA

Email updates

Receive periodic news and updates relating to BioMed Central.

Indexed by

  • CAS
  • Embase
  • MEDLINE
  • PubMed
  • Science Citation Index Expanded
  • Scopus

View all

ISSN: 1471-230X